Home NDC 59762-3328 clindamycin hydrochloride
Product NDC 59762-3328
11-digit product format 597623328
Labeler code 59762
Product ID 59762-3328_8b018de8-bd9a-493a-9069-1f54fcec2069
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name clindamycin hydrochloride
Dosage form CAPSULE
Route ORAL
Labeler Greenstone LLC
Application NDA050162
Marketing category NDA AUTHORIZED GENERIC
Marketing start 1970-05-22
Marketing end 0000-00-00
Substance CLINDAMYCIN HYDROCHLORIDE
Active strength 150 mg/1
Pharmacologic classes Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N050162-001 CLEOCIN HYDROCHLORIDE CLINDAMYCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 N050162-002 CLEOCIN HYDROCHLORIDE CLINDAMYCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 N050162-003 CLEOCIN HYDROCHLORIDE CLINDAMYCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 135 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 c2088c7a36db…2026-10-15 13:18:30 2026-09 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 c2088c7a36db…2026-10-15 13:18:30 2026-09 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 c2088c7a36db…2026-09-14 22:38:34 2026-08 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050162-002 CLEOCIN HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050162-003 CLEOCIN HYDROCHLORIDE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 1988-04-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N050162-001 CLEOCIN HYDROCHLORIDE EQ 75MG BASE CAPSULE / ORAL AB RLD, Approved before 1982 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 2 of 4 · 135 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59762-3328-1 clindamycin hydrochloride 100 in 1 BOTTLE CAPSULE 100 35
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59762-3328 CLINDAMYCIN HYDROCHLORIDE CAPSULE [MYLAN PHARMACEUTICALS INC.] 32 Legacy NDC, 1 package rows 20250529_24595bb3-07ea-4d5f-9bb3-2c2332a1fc62.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 59762-3328-1 59762332801 100 CAPSULE in 1 BOTTLE (59762-3328-1) 100 capsule 1970-05-22 0000-00-00 No No Current